Alterations in the cardiovascular system in patients with cirrhosis - assessment of a haemodynamic profile

Cirrhotic cardiomyopathy (CCM) is a condition concerning heart muscle dysfunction, occurring among

patients with cirrhosis. Cirrhosis leads to the development of a hyperdynamic syndrome, which is

manifested by high cardiac output, increased heart rate and effective arterial blood volume,

accompanied by reduced total systemic vascular resistance.

The aim of the study is to screen patients with cirrhosis, which may lead to earlier diagnosing CCM and hyperdynamic syndrome with its consequences among them.

The study included 70 patients over 18 years old, with cirrhosis, caused by alcohol ([ALD], 22),

autoimmune (26), viral (9) other reasons (13), qualified for liver transplantation. 39 of them were

male. Median age was 47. We disqualified patients with a history of cardiovascular diseases. Each

patient had a 6-minute walking test (6MWT) done and a hemodynamic monitoring using non-invasive hemodynamic monitor device was also performed.

Share This Article